Related Experiment Video
Updated: Jun 24, 2026

07:10
Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)
Published on: April 21, 2019
Allergy prevention - Current recommendations and new insights.
Mimi L K Tang1, Marnie Robinson
1Department of Allergy and Immunology, Royal Children's Hospital, Melbourne, Victoria. mimi.tang@mcri.edu.au
Australian Family Physician
|April 10, 2008
Summary
Allergy prevention strategies focus on high-risk infants with a family history of allergic disease. Breastfeeding and timely introduction of solids are recommended, while maternal dietary restrictions are not.
Area of Science:
- Immunology
- Public Health
- Pediatrics
Background:
- Allergic disease prevalence has significantly increased globally, with Australia experiencing particularly high rates.
- The escalating burden of allergic diseases necessitates effective prevention strategies due to the absence of a cure.
- Underlying factors driving the rise in allergic disease prevalence remain largely unidentified, limiting current prevention approaches.
Observation:
- A family history of allergic disease in a first-degree relative is the sole validated predictor of a child's elevated risk.
- Current evidence does not support maternal dietary restrictions during pregnancy or lactation for allergy prevention.
- Aeroallergen avoidance strategies are not currently recommended for preventing allergic diseases.
Findings:
- Breastfeeding is advised for all infants; partially hydrolysed formula is recommended for high-risk infants when breastfeeding is insufficient.
- Introducing solid foods between 4 to 6 months of age is recommended for infants.
- Delaying the introduction of solids beyond 6 months shows no additional benefit in allergy prevention.
- Insufficient evidence currently exists to support the use of probiotics for allergy prevention.
Implications:
- Allergy prevention efforts should prioritize individuals identified as high-risk based on genetic predisposition.
- Clinical guidelines emphasize tailored prevention strategies focusing on infant feeding practices and early solid introduction.
- Further research is needed to elucidate causative factors and develop novel, evidence-based allergy prevention interventions.
Related Concept Videos
Allergic Reactions
Overview
Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...

